Myonexus Therapeutics
Myonexus Therapeutics is a clinical stage gene therapy company developing first ever treatments for Limb-girdle muscular dystrophy (LGMD) types 2D, 2B, 2E, 2L, and 2C based on research at Nationwide Children’s Hospital, a leader in muscular dystrophy gene therapy discovery and translational research.
- Website: myonexustx.com
Expert Office Hours
Your Questions • Our Experts
Private Appointments
9:00 am – 12:00 pm
2023
| Thu Dec 7 |
2024
| Fri Feb 2 | Fri Apr 5 |
| Fri Jun 7 | Fri Aug 2 |
| Fri Oct 4 | Thu Dec 5 |
Register 2-3 weeks in advance
Have Expertise?
Subscribe to Our Updates!
Why New Albany?
As a community created by innovators for innovators, New Albany offers a robust ecosystem that leverages entrepreneurship, business connectivity, public-private partnerships and quality of life to inspire creativity and accelerate commerce.